Non-Exclusive License Agreement. This Non-Exclusive License Agreement (this “Agreement”) is by and between Icahn School of Medicine at Mount Sinai, a New York not-for-profit education corporation, with a principal place of business at Oxx Xxxxxxx X. Xxxx Place, New York, NY 10029 (“Mount Sinai”) and Heart Test Laboratories, Inc. d/b/a HeartSciences a Texas corporation, with a principal place of business at 500 Xxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxxxx, XX 00000 (referred to herein as (“Licensee”). This Agreement shall become effective upon the Closing (the “Effective Date”), which shall be deemed the Closing Date. Mount Sinai and Licensee are each referred to herein as a “Party” and collectively as the “Parties.” Terms not defined herein shall have the meaning ascribed to them in the Securities Purchase Agreement between the Parties, executed contemporaneously herewith (the “SPA”) and annexed hereto as Exhibit A.
Non-Exclusive License Agreement. Within [***] ([***]) Business Days of the Escrow Agent’s receipt of an Option Notice, Omega and Acuitas will enter into a Non-Exclusive License using the form attached hereto as Exhibit 5.2(b) for the Licensed Products directed to the Reserved Target specified in the relevant Option Notice.
Non-Exclusive License Agreement. Within [**] of the Escrow Agent’s receipt of an Option Notice, Verve and Acuitas will enter into a Non-Exclusive License Agreement using the form specified in Appendix 1.48 for the Licensed Products specified in the relevant Option Notice.
Non-Exclusive License Agreement. This Agreement is entered into as of the 20th day of October, 1999 (“Effective Date”) by and between the Xxxx Xxxxxxxxxx Cancer Research Center, a Washington non-profit corporation (“FHCRC”) and Xcyte Therapies, Inc (“LICENSEE”), a Delaware corporation having a place of business at 0000 Xxxxxxx Xxx X., Xxxxx 000, Xxxxxxx, Xxxxxxxxxx 00000. All references to LICENSEE shall include its AFFILIATES.
Non-Exclusive License Agreement. This Non-Exclusive License Agreement (the "Agreement") is dated this --------- ___ day of March, 2000 and is entered into by and between Xxxxxx Laboratories, an Illinois corporation having a principal place of business at 000 Xxxxxx Xxxx Road, Xxxxxx Park, Illinois, 60064-3500 ("Abbott"), and Anesta Corp., a Delaware ------ corporation having a principal place of business at 0000 Xxxxx Xxxx Way, Salt Lake City, Utah 84116 ("Anesta"). ------ BACKGROUND ----------
Non-Exclusive License Agreement. This Non-Exclusive License Agreement and the attached Appendix A (collectively, the “Agreement”) is made and is effective this day of (the “Effective Date”) between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (“The Regents”), a California corporation having its corporate offices located at 0000 Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000-0000, acting through The Office of Intellectual Property – Industry Sponsored Research of the University of California, Los Angeles, located at 00000 Xxxxxxx Xxxxxx, Xxxxx 000, Xxx Xxxxxxx, XX 00000-0000, and (“Licensee”), a corporation having a principal place of business at RECITALS
Non-Exclusive License Agreement. This Non-exclusive License Agreement (the “Agreement”), effective as of November 30, 2001 (the “Effective Date”), is entered into by and between XOMA Ireland Limited (“XOMA”), an Irish company having offices located at Xxxxxxx Xxxxxxx Xxxxx, Xxxxxxx, Xxxxxx Xxxxx, Xxxxxxx, and Viventia Biotech Inc. (“VIVENTIA”), a Canadian corporation having offices located at 10 Four Seasons Place, Suite 510, Toronto, Ontario, Canada M9B 6H7.
Non-Exclusive License Agreement. This Non-Exclusive License Agreement and the attached Appendix A (collectively, the “Agreement”) is made and is effective this day of , 20 (the “Effective Date”) between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (“The Regents” or “Licensor”), a California corporation having its corporate offices located at 0000 Xxxxxxxx Xxxxxx, Xxxxxxx, Xxxxxxxxxx 00000-0000, acting through The Office of Intellectual Property and Industry Sponsored Research of the University of California, Los Angeles, located at 00000 Xxxxxxx Xxxxxx, Xxxxx 000, Xxx Xxxxxxx, XX 00000-0000, and the undersigned:
Non-Exclusive License Agreement. This Non-Exclusive License Agreement (this “Agreement”), made and entered into as of October 21, 2011 (the “Effective Date”), is by and between, on the one hand, X. Xxxxxxxx-Xx Xxxxx Ltd, a corporation organized under the laws of Switzerland, with an office and place of business at Xxxxxxxxxxxxxxxxx 000, 0000 Xxxxx, Xxxxxxxxxxx (“Roche Basel”) and Xxxxxxxx-Xx Xxxxx Inc., a corporation organized under the laws of the State of New Jersey, with an office and place of business at 000 Xxxxxxxxx Xxxxxx, Xxxxxx, Xxx Xxxxxx 00000, X.X.X. (“Roche Nutley”; Roche Basel and Roche Nutley together referred to as “Roche”), and, on the other hand, Arrowhead Research Corporation, a corporation organized under the laws of the State of Delaware, having a primary business address at 000 Xxxxx Xxxx Xxxxxx, 0xx Xxxxx, Xxxxxxxx, Xxxxxxxxxx 00000(“Arrowhead”) (collectively, the “Parties”, or each separately, a “Party” ).
Non-Exclusive License Agreement. The Reciprocal Easement described above provides Victoria Partners with an easement to use the parking area, and the parties have entered into an agreement to expand the permitted uses for the Reciprocal Easement for the purposes of facilitating entertainment and other attractions in the area. That certain Irrevocable, Non-Exclusive License Agreement by and between ARIA Resort & Hotel Holdings, LLC, a Nevada limited liability company, and Victoria Partners, a Nevada general partnership dated as of July 2, 2012, addresses the various rights and obligations of the Company and the MGM Affiliate respecting the parking easement area.
